Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 18;10:22286. doi: 10.1038/s41598-020-79002-w

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Levels of cell associated unspliced HIV RNA in PBMCs isolated from HIV-infected patients on ART who were under intensification with maraviroc. (A) Copies per million peripheral blood mononuclear cells (PBMCs), (B) relative fold change with respect to baseline and (C) relative fold change with respect to 12 weeks of treatment intensification. The blue shaded box shows the time on maraviroc intensification. BL, baseline; 12w, 12 weeks on maraviroc; 48w, 48 weeks on maraviroc; 12d, 12 weeks after discontinuation of maraviroc. *Baseline sample in patient 3 was not available.